Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Go back to Immunotherapy Clinical Trials - A New Approach to Treating Cancer| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 0.62 -0.03 (4.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $9.09 | |||
| Open | $0.64 | 52 Week Low | $4.02 | |||
| Day High | $0.64 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-0.05 | |||
| Volume | 36,057 | |||||

